Every Newborn Action Plan (ENAP) launched in 2014 was developed in consultation with member states including many organizations and supported by World Health Organization (WHO).
Accurate data are crucial to track progress towards the Global Strategy and the Ending Preventable Maternal Mortality (EPMM)/ENAP vision to end preventable maternal and newborn mortality as well as stillbirth. Impact data, including mortality and birthweight/gestational age and data regarding coverage of interventions to ensure we are reaching those in need, are integral to global governance, finance planning and local program planning. In this regard, the global ENAP technical advisory team together with London School of Hygiene and Tropical Medicine (LSHTM), Nepal Health Research Council (NHRC) and Golden Community is committed to EN-BIRTH study to validate the newborn indicators collected from the health facilities, evaluate the quality of care provided at health facility and validate whether the health facility based indicator can be collected from the periodic national and sub-national survey by 2018. The objective of the study is to evaluate the accuracy and precision of the data collection on women receiving uterotonics, women receiving antenatal corticosteroids, neonatal resuscitation, essential newborn, newborn receiving Kangaroo Mother Care (KMC) and newborn with infection. The study is being conducted at Pokhara Academy of Health Sciences